Assessment of a quantitative multiplex 5’ nuclease real-time PCR for spotted fever and typhus group rickettsioses and Orientia tsutsugamushi  by Prakash, J.A.J. et al.
10.1111/j.1469-0691.2008.02242.x
Assessment of a quantitative multiplex 5¢ nuclease real-time PCR for
spotted fever and typhus group rickettsioses and Orientia tsutsugamushi
J. A. J. Prakash1, M. E. Reller2, N. Barat2 and J. S. Dumler2
1Department of Microbiology, Christian Medical College, Vellore, India and 2Department of Pathology,
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
INTRODUCTION
Scrub typhus, murine typhus and spotted fever
group rickettsioses are re-emerging causes of
acute febrile illness in south and southeast Asia
[1,2], whereas spotted fever group and typhus
group rickettsioses are globally distributed. Data
from the United States suggest both increasing
incidence and serious under-reporting (fewer
than a quarter of cases) [3]. Lack of accurate,
rapid diagnostic tools has limited assessment of
the global burden, distribution and clinical fea-
tures of rickettsioses, including the pathogenicity
of different species [4]. Paired sera, the current
gold standard, at best informs epidemiology,
because diagnoses can be made in retrospect only
if clinical suspicion, follow-up and laboratory
infrastructure enable a convalescent blood sample
to be obtained and tested [5]. Serology also does
not reliably distinguish among species. Because
rickettsial illnesses clinically mimic other causes
of undifferentiated fever that require different
treatment, better diagnostic tools are needed to
guide management and avert needless morbidity
and mortality [1,2]. To address this need, we
sought to develop a quantitative, multiplex
5¢-nuclease real-time PCR assay to diagnose
spotted fever (SFGR) and typhus group (TGR)
rickettsioses, as well as Orientia tsutsugamushi
(OT), the cause of scrub typhus.
METHODS
We used AlleleID 6 (PREMIER Biosoft, Palo Alto, CA, USA)
software to design minor groove binding primers and probes.
Our gene targets included a consensus ompA sequence
(prepared by ClustalX alignment of 23 SFGR ompA sequences),
the Rickettsia typhi genus wide 17-kDa lipoprotein precursor
gene, and the O. tsutsugamushi 56-kDa major outer membrane
protein gene.
After preparing and optimising primers, DNA from cul-
tured bacteria was ampliﬁed, cloned, and the plasmid quantity
determined. Optimisation and determination of analytical
sensitivity was accomplished with DNA from plasmid clones
of multiple species (R. akari, R. conorii, R. felis, R. parkeri,
R. prowazekii, R. rickettsii, R. typhi and O. tsutsugamushi Kato,
Karp and Gilliam) that was detected with SYBR Green.
The assay was further optimised after integration of probes.
The ﬁnal result was a 3-colour Taqman (5¢-nuclease) assay for
the BioRad iQ5 PCR Detection System (Bio-Rad Laboratories,
Hercules, CA, USA). FAM was chosen to detect the ompA gene
common to all SFGR, Texas Red to detect the 17-kDa
lipoprotein precursor gene of Rickettsia spp. with preferential
detection of TGR spp. (R. typhi and R. prowazekii), and HEX to
broadly detect the 56-kD antigen gene of Orientia spp. (OT).
The speciﬁcity of the assay was assessed using DNA from a
variety of genomic bacterial and protozoan species (Anaplasma
phagocytophilum, Ehrlichia canis, Ehrlichia chaffeensis and Neo-
rickettsia helminthoeca; Borrelia burgdorferi, Escherichia coli, Pseu-
domonas aeruginosa, Streptococcus pneumoniae and Staphylococcus
aureus; and Plasmodium falciparum) that can cause acute febrile
syndromes and bloodstream infections. Additionally, normal
human DNA and human HL-60 promyelocytic leukaemia
DNA were used.
Finally,weassessed the sensitivity of the assay todetectDNA
in a blood matrix. We spiked genomic DNA from spotted fever
group Rickettsia (including R. akari, R. conorii, R. felis, R.
montanensis, R. parkeri, R. peacockii and R. rickettsii), TGR (R.
typhi and R. prowazekii), and Orientia spp. (Kato, Karp and
Gilliam strains of OT) into blood. Multiplex validation was
performed using all three primer and probe sets and total DNA
from Rickettsia and Orientia spp. spiked into human blood.
RESULTS
Multiplex analytical sensitivity for all cloned tar-
gets was linear over a range of 2–2 · 105 copies, or
as few as 2000 target copies ⁄mL of each were
detected. Genomic DNA from all SFGR and TGR
species as well as OT strains was detected. Multi-
plexing the assays did not result in a loss of
sensitivity of the assay for SFGR, TGR or OT. The
assays all had very similar efﬁciencies and corre-
lations (FAM efﬁciency 119% and R = 0.99, Texas
Red 115% and 0.998, and HEX 106% and 0.998).
Multiplex analytical speciﬁcity showed no cross-
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reactions among genomic DNA from SFGR, TGR
and OT, nor detected genomic DNA of other
bacterial pathogens in human blood.
CONCLUSIONS
To be useful clinically, a tool for the diagnosis of
rickettsial infections must be able to detect the
pathogen accurately and quickly to enable tar-
geted therapy. An ideal epidemiologic tool would
also be able to distinguish between species, so
that the distribution of existing Rickettsia species
and their vectors may be better understood, and
new species and ecologic niches uncovered [5].
This multiplex quantitative PCR assay holds the
promise of doing both. It detects as few as two
SFGR, TGR or OT DNA gene copies in blood,
distinguishes between them and other closely-
related rickettsiae (Ehrlichia and Anaplasma), and
can be conducted in <3 h. The clinical test
characteristics of this assay need to be determined
to assess its diagnostic effectiveness. Validation of
the assay will require prospective collection of
clinical samples that can be tested by the current
diagnostic standard (paired serology) and by PCR
with blinded interpretation of testing. Concomi-
tant prospective collection of clinical data will
also be important, so that clinical and laboratory
results can be correlated.
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